BTG sees full-year results in line

Specialist healthcare company BTG has said results for the year ending March will be in line with their previous guidance. Revenue is predicted to fall between the range of £108m to £114m with recurring revenue accounting for around £98m to £102m of that. The market consensus for 2010-11 is £110m. The group added integration of the biocompatibles business it bought in January is in line to meet the targeted cost saving of £3m.